Symmetry Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,515
| Closed | -$324K | – | 550 |
|
|
2022
Q2 | $324K | Sell |
1,515
-182
| -11% | -$38.9K | 0.02% | 441 |
|
|
2022
Q1 | $482K | Hold |
1,697
| – | – | 0.03% | 374 |
|
|
2021
Q4 | $639K | Sell |
1,697
-306
| -15% | -$115K | 0.04% | 322 |
|
|
2021
Q3 | $804K | Hold |
2,003
| – | – | 0.05% | 274 |
|
|
2021
Q2 | $741K | Hold |
2,003
| – | – | 0.05% | 302 |
|
|
2021
Q1 | $581K | Hold |
2,003
| – | – | 0.04% | 345 |
|
|
2020
Q4 | $500K | Buy |
2,003
+446
| +29% | +$111K | 0.04% | 372 |
|
|
2020
Q3 | $353K | Buy |
+1,557
| New | +$353K | 0.03% | 434 |
|
|
2019
Q3 | – | Sell |
-2,102
| Closed | -$298K | – | 345 |
|
|
2019
Q2 | $298K | Buy |
2,102
+745
| +55% | +$106K | 0.06% | 251 |
|
|
2019
Q1 | $197K | Buy |
1,357
+825
| +155% | +$120K | 0.03% | 310 |
|
|
2018
Q4 | $60K | Buy |
+532
| New | +$60K | 0.02% | 354 |
|